STAAR SURGICAL COMPANY

NASDAQ: STAA (STAAR Surgical Company)

Kemas kini terakhir: 16 Feb, 9:42AM

16.10

-0.39 (-2.37%)

  • 1H -2.37%
  • 5H -12.12%
  • 1B -0.62%
  • 6B -40.87%
  • Tahun Ke Tarikh -31.78%
  • 1T -8.57%
  • 5T -82.59%
Penutupan Terdahulu 16.49
Buka 16.52
Jumlah Dagangan 805,650
Purata Dagangan (3B) 1,407,739
Modal Pasaran 794,791,872
Harga / Pendapatan (P/E Ke hadapan) 48.78
Harga / Jualan (P/S) 3.90
Harga / Buku (P/B) 2.71
Julat 52 Minggu
14.69 (-8%) — 30.81 (91%)
Tarikh Pendapatan 17 Feb 2026
Margin Keuntungan -25.46%
Margin Operasi (TTM) -81.43%
EPS Cair (TTM) -1.44
Pertumbuhan Hasil Suku Tahunan (YOY) -44.90%
Pertumbuhan Pendapatan Suku Tahunan (YOY) 107.20%
Jumlah Hutang/Ekuiti (D/E MRQ) 10.48%
Nisbah Semasa (MRQ) 4.78
Aliran Tunai Operasi (OCF TTM) -11.69 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 10.73 M
Pulangan Atas Aset (ROA TTM) -5.90%
Pulangan Atas Ekuiti (ROE TTM) -19.14%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Instruments & Supplies (US) Bercampur Bercampur
Medical Instruments & Supplies (Global) Bercampur Menurun
Stok STAAR Surgical Company Menurun Menaik

AISkor Stockmoo

-0.5
Konsensus Penganalisis -0.5
Aktiviti Orang Dalam NA
Volatiliti Harga 0.5
Purata Bergerak Teknikal -2.5
Osilator Teknikal 0.5
Purata -0.50

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
STAA 795 M - - 2.71
MMSI 4 B - 32.84 2.56
LMAT 2 B 0.79% 46.29 6.25
ATRC 2 B - - 3.02
AZTA 1 B - 46.52 0.610
PLSE 970 M - - 18.18

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.
Sektor Healthcare
Industri Medical Instruments & Supplies
Gaya Pelaburan Small Growth
% Dimiliki oleh Orang Dalam 0.64%
% Dimiliki oleh Institusi 109.43%

Pemilikan

Nama Tarikh Syer Dipegang
Sand Grove Capital Management Llp 30 Sep 2025 829,123
Defender Capital, Llc. 31 Dec 2025 668,222
Water Island Capital Llc 30 Sep 2025 658,317
Julat 52 Minggu
14.69 (-8%) — 30.81 (91%)
Julat Harga Sasaran
16.00 (-0%) — 26.00 (61%)
Tinggi 26.00 (Wedbush, 61.49%) Pegang
Median 21.50 (33.54%)
Rendah 16.00 (Wells Fargo, -0.62%) Pegang
Purata 20.70 (28.57%)
Jumlah 1 Beli, 4 Pegang
Harga Purata @ Panggilan 19.21
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
Wells Fargo 05 Mar 2026 16.00 (-0.62%) Pegang 18.57
Stifel 04 Mar 2026 18.00 (11.80%) Pegang 19.22
09 Feb 2026 19.00 (18.01%) Pegang 17.41
Wedbush 03 Feb 2026 26.00 (61.49%) Pegang 18.15
Jefferies 28 Jan 2026 21.50 (33.54%) Beli 19.15
Canaccord Genuity 16 Jan 2026 22.00 (36.65%) Pegang 20.97

Tiada data dalam julat masa ini.

  • 3M
Tarikh Jenis Butiran
02 Feb 2026 Pengumuman STAAR Surgical Appoints Warren Foust and Deborah Andrews Interim Co-CEOs
15 Jan 2026 Pengumuman STAAR Surgical and Broadwood Partners Enter Into Cooperation Agreement
06 Jan 2026 Pengumuman Alcon Terminates Agreement to Acquire STAAR Surgical
06 Jan 2026 Pengumuman Broadwood Partners Comments on STAAR Surgical Shareholders’ Rejection of the Company’s Proposed Sale to Alcon
06 Jan 2026 Pengumuman STAAR Surgical Announces Preliminary Results of Special Meeting of Stockholders
19 Dec 2025 Pengumuman Broadwood Partners Denounces STAAR Surgical’s Fourth Delay of the Shareholder Vote on the Company’s Proposed Sale to Alcon
19 Dec 2025 Pengumuman Alcon Exercises Right to Require STAAR Surgical to Adjourn its Special Meeting of Stockholders
17 Dec 2025 Pengumuman Defender Capital Reiterates Intention to Vote AGAINST STAAR Surgical's Proposed Sale to Alcon Inc.
17 Dec 2025 Pengumuman Broadwood Partners Issues Open Letter to STAAR Surgical Board Pledging Cooperation and Support When Vote on Alcon Transaction Fails
17 Dec 2025 Pengumuman STAAR Stockholders Have a Choice: Vote FOR Alcon’s Certain, Premium $30.75 Per Share Cash Offer or Bear the Downside Risk that Broadwood Has No Credible Plan to Create Stockholder Value
16 Dec 2025 Pengumuman Yunqi Capital Comments on Proxy Advisors’ Updated Recommendations, Urges Shareholders to Continue to Back the Company’s Standalone Trajectory
16 Dec 2025 Pengumuman Independent Industry Analysts Recognize Value Provided to STAAR Stockholders by Amended Alcon Merger Agreement and Merits of Alcon Transaction
16 Dec 2025 Pengumuman Broadwood Partners Comments on ISS Report on Proposed Sale of STAAR Surgical to Alcon
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2026 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda